286 related articles for article (PubMed ID: 31944236)
1. Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.
Katinios G; Casado-Bedmar M; Walter SA; Vicario M; González-Castro AM; Bednarska O; Söderholm JD; Hjortswang H; Keita ÅV
Inflamm Bowel Dis; 2020 Jun; 26(7):974-984. PubMed ID: 31944236
[TBL] [Abstract][Full Text] [Related]
2. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
3. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
Li MR; Jiang K; Zhang QY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):957-60. PubMed ID: 18756966
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
[TBL] [Abstract][Full Text] [Related]
5. Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis.
Ahn JY; Lee KH; Choi CH; Kim JW; Lee HW; Kim JW; Kim MK; Kwon GY; Han S; Kim SE; Kim SM; Chang SK
Dig Dis Sci; 2014 May; 59(5):1001-11. PubMed ID: 24282051
[TBL] [Abstract][Full Text] [Related]
6. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
[TBL] [Abstract][Full Text] [Related]
7. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
Gecse K; Róka R; Séra T; Rosztóczy A; Annaházi A; Izbéki F; Nagy F; Molnár T; Szepes Z; Pávics L; Bueno L; Wittmann T
Digestion; 2012; 85(1):40-6. PubMed ID: 22179430
[TBL] [Abstract][Full Text] [Related]
8. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
[TBL] [Abstract][Full Text] [Related]
9. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.
Coates MD; Mahoney CR; Linden DR; Sampson JE; Chen J; Blaszyk H; Crowell MD; Sharkey KA; Gershon MD; Mawe GM; Moses PL
Gastroenterology; 2004 Jun; 126(7):1657-64. PubMed ID: 15188158
[TBL] [Abstract][Full Text] [Related]
10. Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.
Lundgren D; Rutegård J; Eklöf V; Palmqvist R; Karling P
BMC Gastroenterol; 2016 Nov; 16(1):139. PubMed ID: 27881072
[TBL] [Abstract][Full Text] [Related]
11. Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms.
Moraes L; Magnusson MK; Mavroudis G; Polster A; Jonefjäll B; Törnblom H; Sundin J; Simrén M; Strid H; Öhman L
Inflamm Bowel Dis; 2020 May; 26(6):874-884. PubMed ID: 31901089
[TBL] [Abstract][Full Text] [Related]
12. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation?
Keszthelyi D; Troost FJ; Jonkers DM; Helyes Z; Hamer HM; Ludidi S; Vanhoutvin S; Venema K; Dekker J; Szolcsányi J; Masclee AA
Eur J Pain; 2013 Oct; 17(9):1299-306. PubMed ID: 23529955
[TBL] [Abstract][Full Text] [Related]
13. Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome.
Meira de-Faria F; Casado-Bedmar M; Mårten Lindqvist C; Jones MP; Walter SA; Keita ÅV
Neurogastroenterol Motil; 2021 Nov; 33(11):e14130. PubMed ID: 33797165
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.
Bednarska O; Walter SA; Casado-Bedmar M; Ström M; Salvo-Romero E; Vicario M; Mayer EA; Keita ÅV
Gastroenterology; 2017 Oct; 153(4):948-960.e3. PubMed ID: 28711627
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
[TBL] [Abstract][Full Text] [Related]
16. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome.
Kristjánsson G; Venge P; Wanders A; Lööf L; Hällgren R
Gut; 2004 Dec; 53(12):1806-12. PubMed ID: 15542519
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.
Kotani S; Fukuba N; Kawashima K; Mishima Y; Sonoyama H; Okimoto E; Tada Y; Oka A; Tamagawa Y; Oshima N; Mishiro T; Tobita H; Shibagaki K; Moriyama I; Ishimura N; Kushiyama Y; Fujishiro H; Ishihara S
Scand J Gastroenterol; 2020 May; 55(5):560-564. PubMed ID: 32412797
[No Abstract] [Full Text] [Related]
18. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls.
Rao AS; Camilleri M; Eckert DJ; Busciglio I; Burton DD; Ryks M; Wong BS; Lamsam J; Singh R; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G919-28. PubMed ID: 21836056
[TBL] [Abstract][Full Text] [Related]
19. Irritable Bowel Syndrome-Like Symptoms in Ulcerative Colitis Patients in Clinical Remission: Association with Residual Colonic Inflammation.
Ishihara S; Kawashima K; Fukuba N; Tada Y; Kotani S; Mishima Y; Oshima N; Kinoshita Y
Digestion; 2019; 99(1):46-51. PubMed ID: 30554229
[TBL] [Abstract][Full Text] [Related]
20. Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients.
Buhner S; Hahne H; Hartwig K; Li Q; Vignali S; Ostertag D; Meng C; Hörmannsperger G; Braak B; Pehl C; Frieling T; Barbara G; De Giorgio R; Demir IE; Ceyhan GO; Zeller F; Boeckxstaens G; Haller D; Kuster B; Schemann M
PLoS One; 2018; 13(3):e0193943. PubMed ID: 29529042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
